wound care - Nursing Case Study
Pathophysiology
• Primary mechanism: Inflammation is the initial response to wound injury, characterized by vasodilation and increased permeability, allowing essential immune cells and nutrients to reach the site, initiating repair and preventing infection.
• Secondary mechanism: Proliferation involves fibroblast activity, which synthesizes collagen to form the extracellular matrix and new tissue, while angiogenesis restores blood supply, crucial for delivering oxygen and nutrients to support healing.
• Key complication: Impaired healing can occur due to factors like infection, poor circulation, or diabetes, leading to chronic wounds. This disrupts normal repair processes, prolonging inflammation and impairing tissue regeneration.
Patient Profile
Demographics: 54-year-old male, construction worker
History:
• Key past medical history: Type 2 diabetes, hypertension
• Current medications: Metformin, Lisinopril
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Non-healing wound on left leg
• Key symptoms: Increasing redness and swelling around wound, mild fever, occasional throbbing pain
• Vital signs: Temperature 100.4°F, Blood pressure 148/92 mmHg, Heart rate 96 bpm, Respiratory rate 20 breaths per minute
Section 1
As the wound care team conducts an initial assessment, they note the wound on the patient's left leg measures approximately 3 cm in diameter with irregular edges. The surrounding skin is erythematous and warm to the touch, suggesting a possible localized infection. Purulent drainage is present, and the wound bed appears covered with slough, indicating necrotic tissue that may impede healing. The surrounding edema is palpable, further raising concerns about potential complications. The patient's blood glucose level is 185 mg/dL, which is mildly elevated, potentially interfering with the wound healing process. The wound's chronicity is evident, as it has been present for over four weeks, with minimal signs of granulation, pointing towards a stalled proliferative phase.
Given the patient's background of type 2 diabetes and hypertension, the healthcare team decides to obtain a wound culture to identify any bacterial pathogens that may be contributing to the impaired healing process. Additionally, blood tests are ordered, including a complete blood count (CBC) and C-reactive protein (CRP), to assess for systemic infection and inflammation. The patient's elevated blood pressure and heart rate raise the possibility of increased physiological stress, which could be exacerbating the wound's condition. Moreover, the mild fever suggests a potential systemic inflammatory response, warranting prompt intervention to prevent further complications.
As new diagnostic results come in, the wound culture reveals the presence of Staphylococcus aureus, a common pathogen known to cause wound infections, particularly in diabetic patients. The CBC indicates leukocytosis, with a white blood cell count of 13,000/mm³, reinforcing the suspicion of infection. The CRP level is elevated at 12 mg/L, signifying heightened inflammatory activity. These findings necessitate the initiation of targeted antibiotic therapy, taking into account the patient's penicillin allergy, to address the bacterial infection and mitigate the risk of further complications. The healthcare team is now tasked with closely monitoring the patient's response to the intervention, adjusting the care plan as necessary to support the healing process.
Section 2
As the healthcare team begins the targeted antibiotic therapy, the patient's status is closely monitored for any changes, particularly given the history of type 2 diabetes and the ongoing wound infection. Within 48 hours, there is a noticeable shift in the patient's condition. The initial signs of improvement are encouraging; the patient's body temperature stabilizes to 37.2°C, and the erythema surrounding the wound shows a slight reduction, indicating a potential positive response to the antibiotics. However, the edema persists, and there is still significant purulent drainage, suggesting that while the systemic response is improving, localized infection control remains a challenge.
Despite the initial signs of systemic improvement, a new complication emerges. The patient's wound pain increases, now rated at 7/10 on the pain scale, which is a significant change from the previous report of 5/10. The patient also reports increased discomfort and a sensation of throbbing in the affected leg. On re-assessment, the healthcare team notes the development of a new, smaller ulceration adjacent to the original wound, measuring approximately 1 cm in diameter. This raises concerns about the spread of infection or possible vascular compromise, necessitating further investigation into the patient's peripheral circulation and potential ischemic changes due to unmanaged hypertension.
In response to these developments, the healthcare team decides to adjust the care plan. They initiate a consultation with a vascular specialist to assess the possibility of peripheral arterial disease, given the patient's comorbid conditions and the presentation of new ulcerations. Additionally, they consider the use of advanced wound care modalities, such as negative pressure wound therapy, to enhance local wound healing and manage exudate. The team also reinforces the importance of optimizing blood glucose levels as part of the integrated management strategy to prevent further complications and support wound healing. The situation emphasizes the need for continued vigilance and adaptability in the patient's care plan, highlighting the complexity of managing chronic wounds in patients with multiple comorbidities.
Section 3
The vascular specialist conducts a thorough assessment of the patient’s peripheral circulation. During the examination, diminished pulses are noted in the affected leg, particularly the dorsalis pedis and posterior tibial arteries. An ankle-brachial index (ABI) test is performed, revealing a value of 0.7, indicative of moderate peripheral arterial disease. This finding correlates with the patient's history of hypertension and type 2 diabetes, suggesting that the increased wound pain and new ulceration may be due to compromised blood flow, contributing to delayed wound healing.
Laboratory tests are reviewed, revealing an elevated white blood cell count of 13,500/mm³, suggesting a persistent inflammatory response. Glycated hemoglobin (HbA1c) levels return at 8.2%, indicating suboptimal long-term glycemic control. These results underscore the importance of integrated management to address both the infection and underlying comorbidities. The healthcare team emphasizes the need for strict blood sugar management, potentially adjusting the patient’s diabetic regimen, to enhance overall healing.
In light of the diagnostic findings, the care plan is adjusted to include the initiation of cilostazol to improve peripheral circulation and enhance wound healing. Additionally, the team implements negative pressure wound therapy to manage the persistent exudate and promote granulation tissue formation. The patient is also educated on lifestyle modifications, including dietary changes and smoking cessation, to improve vascular health. These interventions are aimed at addressing both the immediate wound care needs and the underlying conditions contributing to the chronicity of the wound, paving the way for improved outcomes in the patient's ongoing care journey.
Section 4
Several weeks into the adjusted care plan, the patient returns for a follow-up appointment. During the visit, the healthcare team conducts a comprehensive evaluation to assess the response to interventions and monitor for any new complications. The patient reports a slight reduction in wound pain, and upon examination, there is evidence of some granulation tissue formation within the ulcer. However, the wound remains slow to heal, and there is persistent moderate exudate despite the ongoing negative pressure wound therapy.
Vital signs reveal a blood pressure of 145/90 mmHg and a resting heart rate of 88 beats per minute. The patient's weight remains stable, but there is a noted increase in peripheral edema in the affected leg. Laboratory results show a decrease in the white blood cell count to 11,500/mm³, indicating a partial reduction in the inflammatory response. However, concern arises as a new laboratory test reveals an elevated C-reactive protein (CRP) level of 12 mg/L, suggesting ongoing systemic inflammation. Furthermore, the HbA1c remains elevated at 8.0%, underscoring the continued need for tighter glycemic control.
In light of these findings, the healthcare team discusses the potential for underlying infection or further vascular complications contributing to the persistent edema and delayed wound healing. Given the patient's history and current status, there is consideration of introducing a low-dose diuretic to manage fluid retention while maintaining vigilance for signs of worsening peripheral arterial disease. The team also emphasizes the importance of optimizing the patient's diabetic regimen and reinforces lifestyle modifications, particularly focusing on the necessity of smoking cessation and dietary adjustments. These steps aim to address the multifaceted challenges the patient faces, paving the way for better vascular health and enhanced wound healing.
Section 5
Several weeks after the introduction of the low-dose diuretic and adjustments to the patient's diabetic regimen, the patient returns for a follow-up evaluation. During this visit, the healthcare team notes a slight improvement in peripheral edema, with less swelling observed in the affected leg. The patient reports feeling somewhat less discomfort, attributing this to a combination of the diuretic's effects and adherence to dietary modifications. However, upon examining the wound, there is still moderate exudate present, and the granulation tissue remains fragile, raising concern about the potential for further complications.
Vital signs show a blood pressure of 138/85 mmHg and a resting heart rate of 85 beats per minute, indicating some improvement in cardiovascular parameters. However, new laboratory results reveal that while the white blood cell count has normalized to 9,800/mm³, the CRP level remains elevated at 10 mg/L, suggesting persistent inflammation despite the partial reduction. Moreover, a recent Doppler ultrasound of the affected leg indicates a slight reduction in blood flow, raising suspicions of progressing peripheral arterial disease, which could be contributing to the sluggish healing process.
Given these findings, the healthcare team decides to adjust the care plan further. They consider initiating a trial of a vasodilator to improve peripheral circulation and reassess the patient's anticoagulation therapy to manage the risk of vascular complications. Additionally, the team reiterates the importance of ongoing lifestyle interventions, such as continuing the smoking cessation efforts and maintaining strict glycemic control, as crucial components of the patient's comprehensive care strategy. These combined efforts aim to address the underlying vascular issues, reduce systemic inflammation, and ultimately enhance the wound healing trajectory.